| Literature DB >> 31887213 |
Ningxiao Li1, Md Tariqul Islam1, Seogchan Kang1.
Abstract
Trichoderma has been used as an alternative to synthetic pesticides to control a variety of phytopathogenic fungi, oomycetes, and nematodes. Although its mechanism of pathogen suppression has been extensively studied, how Trichoderma interacts with non-target microbes is not well understood. Here, we investigated how two Trichoderma biological control agents (BCAs) interact with rhizosphere bacteria isolated from a tomato plant via secreted proteins, metabolites, and volatile compounds (VCs). Culture filtrates (CFs) of T. virens and T. harzianum, containing secreted proteins and metabolites, strongly inhibited (>75% reduction in growth) 39 and 19, respectively, out of 47 bacterial strains tested. Their CFs inhibited the remaining strains at lower degrees. Both metabolites and proteins are involved in inhibiting bacteria, but they seem to antagonize each other in inhibiting some strains. Trichoderma and bacteria suppressed the growth of each other using VCs. The secretion of antibacterial and antifungal molecules by T. virens and T. harzianum was significantly affected by VCs from some bacteria, suggesting that both Trichoderma BCAs and rhizosphere bacteria use VCs to influence each other in multiple ways. In light of these results, we discuss how metabolite-mediated interactions can potentially affect the effectiveness of biocontrol.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31887213 PMCID: PMC6936802 DOI: 10.1371/journal.pone.0227228
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains used.
| Strain | Taxon | Phylum (family) | Accession # |
|---|---|---|---|
| LS9 | Firmicutes ( | MK591847 | |
| TS4 | Firmicutes ( | MK591872 | |
| TS17 | Firmicutes ( | MK591883 | |
| LS4 | Firmicutes ( | MK591842 | |
| TS15 | Firmicutes ( | MK591881 | |
| LR2 | Firmicutes ( | MK591851 | |
| LS3 | Firmicutes ( | MK591841 | |
| LS8 | Firmicutes ( | MK591846 | |
| LS5 | Firmicutes ( | MK591843 | |
| TS13 | Firmicutes ( | MK591879 | |
| LR1* | Firmicutes ( | MK591850 | |
| LR3 | Firmicutes ( | MK591852 | |
| TS5 | Deinococcus-Thermus ( | MK591873 | |
| LR18 | Alpha-Proteobacteria ( | MK591866 | |
| TS7 | Alpha-Proteobacteria ( | MK591875 | |
| TS2 | Gamma-Proteobacteria ( | MK591871 | |
| TS6 | Gamma-Proteobacteria ( | MK591874 | |
| LS11 | Gamma-Proteobacteria ( | MK591860 | |
| LR8 | Gamma-Proteobacteria ( | MK591857 | |
| LR6 | Gamma-Proteobacteria ( | MK591855 | |
| LS1 | Gamma-Proteobacteria ( | MK591839 | |
| LR5 | Gamma-Proteobacteria ( | MK591854 | |
| TS8 | Gamma-Proteobacteria ( | MK591876 | |
| LR4 | Gamma-Proteobacteria ( | MK591853 | |
| LS10 | Gamma-Proteobacteria ( | MK591848 | |
| TS9 | Gamma-Proteobacteria ( | MK591877 | |
| TS16 | Gamma-Proteobacteria ( | MK591882 | |
| LS2 | Bacteroidetes ( | MK591840 | |
| LS6 | Bacteroidetes ( | MK591844 | |
| LR9 | Actinobacteria ( | MK591858 | |
| LR15 | Actinobacteria ( | MK591863 | |
| LR13 | Actinobacteria ( | MK591861 | |
| LR17 | Actinobacteria ( | MK591865 | |
| LR20 | Actinobacteria ( | MK591868 | |
| LS7 | Actinobacteria ( | MK591845 | |
| LR16 | Actinobacteria ( | MK591864 | |
| LR21 | Actinobacteria ( | MK591869 | |
| LR19 | Actinobacteria ( | MK591867 | |
| LR7 | Actinobacteria ( | MK591856 | |
| LR10 | Actinobacteria ( | MK591859 | |
| LR11 | Actinobacteria ( | MK591860 | |
| TR3 | Actinobacteria ( | MK591885 | |
| TS10 | Deinococcus-Thermus ( | MK591878 | |
| TR1 | Actinobacteria ( | MK591884 | |
| LR14 | Gamma-Proteobacteria ( | MK591862 | |
| TS1 | Beta-Proteobacteria ( | MK591870 | |
| TS14 | Gamma-Proteobacteria ( | MK591880 |
Strains cultured using Luria Broth and Tryptone Yeast Extract were labeled as L and T, respectively. R and S indicate root surface and soil, respectively. The order of appearance is based on their phylogenetic positions.
* indicates the 19 strains used for multiple treatments described in this study.
Identity at the genus and family levels was assigned based on the classification in the SILVA database.
GenBank accession number.
Fig 1Bacterial growth responses to metabolites and proteins secreted by Trichoderma.
Tv and Th correspond to T. virens and T. harzianum, respectively. Growth of diverse bacteria (Table 1) and E. coli under the following treatments was measured: (A) CF (Trichoderma culture filtrate); (B)–Met (CF after removing secreted metabolites via dialysis); (C) AM (agar medium after removing Trichoderma cultured on cellophane membrane); and (D) VC (exposure to Trichoderma volatile compounds). OD600 (Treatments A and B) or colony number (Treatments C and D) was measured in triplicates to calculate the degree of growth inhibition/enhancement after each treatment (see S1 Table for the exact degree of growth inhibition or enhancement by each treatment). Results were color-coded to provide an overview of their growth under the four different culture conditions. The phylogenetic tree was generated using their 16S rRNA sequences.
Fig 2Growth of three bacteria in diluted CFs of T. harzianum.
LR1, LR3 and E. coli were cultured in undiluted and diluted (1:1 and 1:3) CFs. Growth inhibition (%) shown corresponds to the mean ± SE of data from three replicates. Different letters indicate a significant difference between treatments according to Tukey’s test at P≤0.05.
Fig 3Proteinase K treatment to evaluate the contribution of secreted proteins in inhibiting bacterial growth.
Degrees of growth inhibition of (A) LR1 and (B) LR3 by CF and–Met of T. harzianum after Proteinase K treatment are shown. Values shown correspond to the mean ± SE of data from three replicates.
Fig 4Inhibition of Trichoderma by bacterial VCs.
Colony diameters of (A) T. virens and (B) T. harzianum after co-cultivation with LR1, TS6, TS9 and E. coli as well as un-inoculated LB plates (Control) are shown. Values shown correspond to the mean ± SE of data from three replicates. Different letters indicate a significant difference between treatments according to Tukey’s test at P≤0.05.
Fig 5Effect of bacterial VCs on the secretion of antibacterial molecules from Trichoderma.
Degrees of growth inhibition (%) of LS1 in the extracts derived from the plates used for co-culturing (A) T. virens and (B) T. harzianum with LR1, TS6, TS9 and E. coli as well as un-inoculated LB plates (Control) are shown. Values shown correspond to the mean ± SE of data from three replicates. Different letters indicate significant differences between treatments based on Tukey’s test at P≤0.05.
Fig 6Effect of bacterial VCs on the secretion of antifungal molecules from Trichoderma.
Colony diameters of F. oxysporum NRRL54003 on plates used for co-culturing (A) T. virens and (B) T. harzianum with LR1, TS6, TS9 and E. coli as well as un-inoculated LB plates (Control) are shown. Values shown correspond to the mean ± SE of data from three replicates. Different letters indicate significant differences between treatments based on Tukey’s test at P≤0.05.